semaglutide 2.0 mg approval UT San Antonio study: As FDA approved for weight management, calls to poison control centers skyrocketed in the U.S A more affordable alternative to
Description
Jones DW, Ferdinand KC, Taler SJ et al (2025) 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Image Credit: lucigerma / Shutterstock.com Introduction This article summarizes how oral glucagon-like peptide-1 (GLP-1) receptor agonists address weight-loss challenges, improve absorption, and enhance tolerability, as well as the promising future of GLP-1/glucose-dependent insulinotropic polypeptide (GIP) dual therapies

Jama 326, 129130

(2025, December 17)

Additionally, its ability to regulate insulin and reduce inflammation supports long-term health